Blinking and eyelid myoclonia: Characteristics and correlations of eyelid movements.

PURPOSE: Eyelid myoclonia (EM) is considered a seizure type and has been described in several epileptic conditions. Previous studies reported that EM are precipitated only by slow eye closure, but little is known about the characteristics of blinking in patients with EM seizures and differences in precipitation of EM by different kinds of eye closure. We analyzed by video-EEG the characteristics of blinking and eye closure in these patients. METHOD: Twenty patients with EM had a video-EEG protocol with eyelid sensors. Semiology and rate of blinking and EM were analyzed. Statistical analysis was performed and p-values <0.05 were considered significant. RESULTS: Seventeen cases (mean age 20.7, range 3-35) were women, 10 had EM as the main seizure type and between the others, all, but one, had criteria to Juvenile Myoclonic Epilepsy. All patients presented EM, 18 spontaneously during awake, 10 on eye closure and one only during intermittent photic stimulation. EM assumed the form of flicker, flutter or jerk, accompanied by generalized discharges, spiky posterior alpha, theta rhythm or absence of any EEG abnormality. Analysis of the characteristics of blinking had no statistics differences between patients and healthy subjects. The rate of blinks and EM increased during speech and decreased during reading. EM never occurred during blinking or in the dark. CONCLUSIONS: Despite normal physiology of blinking, EM can manifest as jerk, flicker or flutter, with or without EEG abnormalities and independently of IPS, suggesting that eye closure sensitivity seems to include both, a motor and a visual component.

Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience.

Retrospective review was performed of children aged <3 years with epileptic spasms at our center from 2004-2010. Short-term (<6 months) and long-term (≥6 months) outcomes were assessed. We included 173 children (104 boys; median age of onset, 6.8 months) with epileptic spasms of known (62%) and unknown (38%) etiology. Treatments included adrenocorticotropic hormone (n = 103), vigabatrin (n = 82), phenobarbital (n = 34), and other agents (n = 121). Short-term treatment with adrenocorticotropic hormone and vigabatrin provided better epileptic spasm control in groups with known and unknown etiology than other agents. At follow-up (6-27 months), 54% of children manifested seizures, and 83% manifested developmental delay. Known etiology was a predictor of poor developmental outcome (P = 0.006), whereas bilateral/diffuse brain lesions predicted both poor development and seizures (P = 0.001 and 0.005, respectively). Initial presentations of epileptic spasms with hypotonia or developmental delay most strongly predicted both seizures and neurodevelopmental outcomes (P < 0.001). In a child presenting with epileptic spasms with developmental delay or hypotonia, no specific treatment may offer superior benefit.

Physiological and electroencephalographic responses to acute exhaustive physical exercise in people with juvenile myoclonic epilepsy.

Although the available evidence suggests that exercise may positively affect epilepsy, whether this effect is applicable to different types of epilepsy has not been established. Physiological responses during rest, acute physical effort, and a recovery period were studied by concomitant analysis of cerebral electric activity using EEGs in subjects with juvenile myoclonic epilepsy (JME) and healthy controls. In addition, level of habitual physical activity, body composition, and 1 week of actigraphy monitoring data were evaluated. Twenty-four subjects (12 with JME and 12 controls) participated in this study. Compared with the control group, the JME group had a significantly lower V˙O(2) at rest (13.3%) and resting metabolic rate (15.6%). The number of epileptiform discharges in the JME group was significantly reduced during the recovery period (72%) compared with the resting state. There were no significant differences between the JME and control groups in behavioral outcomes and sleep parameters evaluated by actigraphy monitoring. The positive findings of our study strengthen the evidence for the benefits of physical exercise for people with JME.

Experience with lacosamide in a series of children with drug-resistant focal epilepsy.

We report our pediatric experience with lacosamide, a new antiepileptic drug, approved by the US Food and Drug Administration as adjunctive therapy in focal epilepsy in patients more than 17 years old. We retrospectively reviewed charts for lacosamide use and seizure frequency outcome in patients with focal epilepsy (Wilcoxon signed rank test). Sixteen patients (7 boys) were identified (median dose 275 mg daily, 4.7 mg/kg daily; mean age 14.9 years, range 8-21 years). Patients were receiving a median of 2 antiepileptic drugs (interquartile range [IQR] 1.7-3) in addition to having undergone previous epilepsy surgery (n=3), vagus nerve stimulation (n=9), and ketogenic diet (n=3). Causes included structural (encephalomalacia and diffuse encephalitis, 1 each; stroke in 2) and genetic abnormalities (Aarskog and Rett syndromes, 1 each) or cause not known (n=10). Median seizure frequency at baseline was 57 per month (IQR 7-75), and after a median follow-up of 4 months (range 1-13 months) of receiving lacosamide, it was 12.5 per month (IQR 3-75), (P<0.01). Six patients (37.5%; 3 seizure free) were classified as having disease that responded to therapy (≥50% reduction seizure frequency) and 10 as having disease that did not respond to therapy (<50% in 3; increase in 1; unchanged in 6). Adverse events (tics, behavioral disturbance, seizure worsening, and depression with suicidal ideation in 1 patient each) prompted lacosamide discontinuation in 4/16 (25%). This retrospective study of 16 children with drug-resistant focal epilepsy demonstrated good response to adjunctive lacosamide therapy (median seizure reduction of 39.6%; 37.5% with ≥50% seizure reduction) without severe adverse events.

Prognosis of juvenile myoclonic epilepsy is related to endophenotypes.

PURPOSE: To investigate if phenotypic variations have prognostic implications in juvenile myoclonic epilepsy (JME). METHODS: Sixty-five consecutive JME patients had video-EEG recording and were followed for at least three years. Reflex traits were defined as seizures and/or EEG discharges induction by eye-closure, photic stimulation, language, praxis or calculation. Patients had psychiatric evaluation and answered to STAI (State-Trait Anxiety Inventory). Seizure control was classified according to Prasad et al. (2003).(24) Patients were divided into Group 1: good seizure control and Group 2: moderate or poor seizure control. Video-EEG/EEG evaluation was repeated in 21 patients. RESULTS: Forty of 65 (61.5%) patients reached good seizure control, 25 (38.5%) of whom became seizure free. Group 2 patients had longer epilepsy duration (13.9±9.0 vs. 8.7±8.2; p=0.019); higher prevalence of the combination of all three seizure types (72.0% vs. 30.0%; p=0.003); discharges in baseline EEG (56.0% vs. 22.5%; p=0.008); seizure recording (68% vs. 20%; p<0.001) and sensitivity to praxis (63.6% vs. 29.6%; p=0.023). Compared to seizure-free patients, those with persistent seizures presented younger age at epilepsy onset (12.6±3.33 years vs. 15.4±5.47 years; p=0.015); higher prevalence of personality disorders (25% vs. 4%; p=0.029); higher scores in STAI-T (45.9±11.31 vs. 36.6±11.43; p=0.011) and higher incidence of sensitivity to praxis (58.6% vs. 25.0%; p=0.04) and to language (53.8 vs. 16.7%; p=0.026) tasks. Repetition of EEG/video-EEG revealed a parallel evolution of reflex traits disappearance and seizure control. DISCUSSION: Clinical features and reflex traits have prognosis implications in JME.

Revisão terminológica e conceitual para organização de crises e epilepsias: relato da Comissão da ILAE de Classificação e Terminologia, 2005-2009. Novos Paradigmas? / Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. New paradigms?

Introdução: A organização das crises epilépticas e epilepsias vem sendo descrita em classificações organizadas pela Liga Internacional contra a Epilepsia (International League Against Epilepsy, ILAE) há cerca de meio século. Segundo estes documentos iniciais aperfeiçoados na década de 1980, as crises foram divididas em focais ou generalizadas, de acordo com o seu modo de início, ou em uma região específica do cérebro ou de forma bilateral, respectivamente. A etiologia das epilepsias foi considerada idiopática, sintomática ou criptogênica. Recentemente ampla discussão na comunidade científica surgiu após a publicação em 2010 de uma revisão terminológica e conceitual da Comissão de Classificação e Terminologia da ILAE. Objetivo/Método: Divulgação em Português do resumo e comentários da discussão da “Revisão terminológica e conceitual para organização de crises e epilepsias: Relato da Comissão de Classificação e Terminologia da ILAE, 2005-2009” a fim de apresentá-la aos profissionais da área de saúde dos países de língua portuguesa. Resultados: Os termos generalizado e focal foram redefinidos; crises que ocorrem em redes neuronais bilateralmente distribuídas que rapidamente as engajam são generalizadas; e aquelas que ocorrem dentro de redes delimitadas a um hemisfério ou discretamente localizadas ou mais amplamente distribuídas são focais. A classificação de crises generalizadas foi simplificada. As crises focais devem ser descritas de acordo com suas manifestações (por ex., discognitiva, motora, etc). Os conceitos generalizado e focal não se aplicam a síndromes eletroclínicas. Genético, metabólico-estrutural e desconhecido representam conceitos modificados para substituir os termos idiopático, simtomático e criptogênico, respectivamente. Nem todas as epilepsias são reconhecidas como síndromes eletroclínicas. A organização da epilepsia é feita pela especificadade, a saber, síndromes eletroclínicas, epilepsias não sindrômicas com causa estrutural ou metabólica, e epilepsias de causa desconhecida. Classes naturais (por ex. causa específica subjacente, idade de início, tipos associados de crises) ou agrupamentos pragmáticos (por ex. encefalopatia epiléptica, síndromes eletroclínicas auto-limitadas) podem servir tanto para organizar o conhecimento sobre formas reconhecidas de epilepsia como facilitar a identificação de outras novas. Várias opiniões dos especialistas internacionais sobre essa terminologia foram divulgadas e uma revisão ampliada será apresentada em 2013 pela Comissão de Classificação e Terminologia da ILAE. Conclusão: A Comissão de Classificação e Terminologia da ILAE (2005-2009) revisou conceitos, terminologia e abordagens para classificar crises e formas de epilepsia tendo publicado em 2010 os resultados do grupo de discussão vigentes nessa data e os resultados finais serão divulgados em 2013.

Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. New paradigms? Introduction: The categorization of epileptic seizures and epilepsies has been described in organized Classifications by the International League Against Epilepsy (ILAE) in the last 50 years. According to these initial documents which have been reviewed in the 1980ths, epileptic seizures were divided in partial (focal) and generalized, regarding its onset type, either in one specific area in the brain or in a bilateral pattern, respectively. The etiology of the epilepsies were then considered to be idiopathic, symptomatic or criptogenic. Recently a broad discussion has emerged since the publication of the document of the Commission on Classification and Terminology of ILAE in 2010. Objetive/Method: Divulgation in Portuguese of the summary and comments of the “Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009” in order to present it to the Health personnel of the Portuguese Speaking countries. Results: Generalized and focal are redefined for seizures as occurring in and rapidly engaging bilaterally distributed networks (generalized) and within networks limited to one hemisphere and either discretely localized or more widely distributed (focal). Classification of generalized seizures is simplified. No natural classification for focal seizures exists; focal seizures should be described according to their manifestations (e.g., dyscognitive, motor, etc). The concepts of generalized and focal do not apply to electroclinical syndromes. Genetic, structural-metabolic, and unknown represent modified concepts to replace idiopathic, symptomatic, and cryptogenic, respectively. Not all epilepsies are recognized as electroclinical syndromes. Organization of forms of epilepsies is done by specificity, as follows: electroclinical syndromes, nonsyndromic epilepsies with structural-metabolic causes, and epilepsies of unknown cause. Natural classes (e.g., specific underlying cause, age at onset, associated seizure type), or pragmatic groupings (e.g., epileptic encephalopathies, self-limited electroclinical syndromes) may serve as the basis for organizing knowledge about recognized forms and facilitate identification of new ones. Several international specialist opinions about this report were divulged and a new report will be presented in 2013 by the Commission of Classification and Terminology of ILAE. Conclusion: The ILAE Commission on Classification and Terminology has revised concepts, terminology, and approaches for classifying seizures and forms of epilepsy and the results of the discussion group were published in 2010 and the final report will be released in 2013.

The integrity of corpus callosum and cluster B personality disorders: a quantitative MRI study in juvenile myoclonic epilepsy.

Evidence suggests increased prevalence of cluster B personality disorders (PD) among patients with juvenile myoclonic epilepsy (JME), which has been associated with worse seizure control and more psychosocial dysfunctions. A preliminary voxel-based morphometry study demonstrated corpus callosum (CC) volume reduction in patients with JME and cluster B PD, particularly in the posterior midbody and isthmus. In this study we aimed to follow up these results with region of interest analysis. Sixteen JME patients with cluster B PD, 38 JME patients without any psychiatric disorder, and 30 demographically matched healthy controls submitted to a psychiatric evaluation and a magnetic resonance imaging scan. The total and regional callosal areas were obtained from the midsagittal slice using a semi-automated program. Psychiatric evaluation was performed through SCID-I and -II. Significant reductions in the posterior region of the CC were observed in the JME with PD group relative to the other groups. These data support previous findings of callosal reductions in cluster B PD, as well as a possible involvement of CC in patients with JME and such personality characteristics.

Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.

PURPOSE: Personality traits characterized by emotional instability and immaturity, unsteadiness, lack of discipline, hedonism, frequent and rapid mood changes, and indifference toward one's disease have been associated with patients who have juvenile myoclonic epilepsy (JME). Literature data demonstrate worse seizure control and more psychosocial dysfunctions among patients with JME who have those traits. In this controlled study we performed a correlation analysis of psychiatric scores with magnetic resonance spectroscopy (MRS) values across JME patients, aiming to verify the existence of a possible relation between frontal lobe dysfunction and the prevalence of personality disorders (PDs) in JME. METHODS: Sixteen JME patients with cluster B PDs, 41 JME patients without any psychiatric disorder, and 30 healthy controls were submitted to a psychiatric evaluation and to a quantitative multivoxel MRS of thalamus; insula; cingulate gyrus; striatum; and frontal, parietal, and occipital lobes. Groups were homogeneous according to age, gender, and manual dominance. Psychiatric evaluation was performed through the Scheduled Clinical Interview for DSM-IV, Axis I and II (SCID I and II, respectively). RESULTS: A significant reduction of N-acetyl-aspartate over creatinine (NAA/Cr) ratio was observed mainly in the left frontal lobe in the JME and PD group. In addition, a significant increase in the glutamate-glutamine over creatinine GLX/Cr ratio was also observed in this referred region in the same group. DISCUSSION: These data support the hypothesis that PDs in JME could represent neuronal dysfunction and possibly a more severe form of this epileptic syndrome.

Personality traits related to juvenile myoclonic epilepsy: MRI reveals prefrontal abnormalities through a voxel-based morphometry study.

Studies involving juvenile myoclonic epilepsy (JME) patients have demonstrated an elevated prevalence of cluster B personality disorders (PD) characterized as emotional instability, immaturity, unsteadiness, lack of discipline, and rapid mood changes. We aimed to verify a possible correlation between structural brain abnormalities in magnetic resonance image (MRI) and the PD in JME using voxel-based morphometry (VBM). Sixteen JME patients with cluster B PD, 38 JME patients without psychiatric disorders, and 30 healthy controls were submitted to a psychiatric evaluation through SCID I and II and to a MRI scan. Significant reduction in thalami and increase in mesiofrontal and frontobasal regions' volumes were observed mainly in JME patients with PD. Structural alterations of the orbitofrontal cortex (OFC), involved in regulation of mood reactivity, impulsivity, and social behavior, were also observed. This study supports the hypothesis of frontobasal involvement in the pathophysiology of cluster B PD related to JME.

Drug-induced gingival enlargement - Part II. Antiepileptic drugs: not only phenytoin is involved

INTRODUCTION: Gingival enlargement is the term now used to describe medication-related gingival overgrowth or gingival hyperplasia, a common reactionary phenomenon that occurs with the use of several types of therapeutic agents, including antiepileptic drugs. This disorder has been recognized since 1939, shortly after the introduction of phenytoin. METHODS: Review of literature concerning etiology, pathogenesis and management of antiepileptic drug induced gingival enlargement. CONCLUSIONS: It is important that neurologists become aware of the potential etiologic agents of antiepileptic drug induced gingival enlargement and its characteristic features in order to be able to prevent, diagnose and successfully manage it.

INTRODUÇÃO: Hipertrofia gengival é o termo usado na atualidade para descrever aumento gengival ou hiperplasia gengival, um fenômeno comum que ocorre com o uso de vários tipos de agentes terapêuticos, incluindo drogas antiepilépticas. Este distúrbio foi descrito em 1939, logo após a introdução da fenitoína. MÉTODOS: Revisão da literatura em relação a etiologia, patogênese e manejo da hipertrofia gengival induzida por drogas antiepilépticas. CONCLUSÕES: É importante que neurologistas estejam conscientes dos agentes etiológicos em potencial da hipertrofia gengival induzida por drogas antiepilépticas e de suas características a fim de preveni-la, diagnosticá-la e tratá-la de modo satisfatório.

Occipital intermittent rhythmic delta activity in absence epilepsy.

Occipital intermittent rhythmic delta activity (OIRDA) is considered good prognostic factor in typical absences (TA). We report electroclinical evolution in 14 patients with TA and OIRDA, which performed video-EEG. Seven patients were female; 9 had childhood absence epilepsy and the others did not present electroclinical characteristics for syndromic classification according to ILAE's classification (1989). Pyknolepsy was referred to in 13; TA was the only seizure type in 13; one had generalized tonic-clonic seizures (GTCS) and three had myoclonic jerks during TA. VPA monotherapy controlled seizures in 11, diVPA and ESM, in one each. After seizure control EEG normalized in 10 while in three, spike-wave complexes (SWC) persisted, accompanied by OIRDA in one. Finally in another, seizures were not controlled and SWC and OIRDA persisted. In conclusion, we observed in this series of TA and OIRDA with onset before 10 years, pyknolepsy as common finding and few GTCS. VPA controlled seizures in most cases and EEG normalized in 76.92%. We suggest that OIRDA could be considered good prognostic factor in TA associated with SWC and of epileptiform nature leading to appropriate investigation.

Occipital intermittent rhythmic delta activity in absence epilepsy

Atividade occipital delta rítmica intermitente (AODRI) é considerada fator de bom prognóstico em crises de ausência típica (AT). Neste estudo relatamos a evolução eletroclínica de 14 pacientes com AT e AODRI que realizaram vídeo-EEG. Sete pacientes eram do sexo feminino; nove tinham epilepsia ausência da infância e os outros não apresentavam características eletroclínicas para classificação sindrômica de acordo com a classificação da ILAE (1989). Picnolepsia foi relatada em 13; AT foi o único tipo de crise em 13; um tinha crises generalizadas TCG e três, abalos mioclônicos durante AT. Monoterapia com VPA controlou as crises em 11, diVPA e ESM, em um cada. Após o controle das crises, o EEG normalizou em 10; em três, complexos de espícula-onda (CEO) persistiram, acompanhados por AODRI em um. Finalmente em outro, as crises não foram controladas, persistindo CEO e AODRI. Concluindo, observamos nesta série de AT e AODRI, com início antes dos 10 anos, picnolepsia freqüente e poucas crises TCG. VPA controlou as crises na maioria dos casos e o EEG normalizou em 76,92%. Sugerimos que AODRI possa ser considerada um fator de bom prognóstico em AT associada a CEO e de possível natureza epileptiforme, levando por sua vez, à investigação apropriada.

Allelic variants of the gamma-aminobutyric acid-A receptor alpha1-subunit gene (GABRA1) are not associated with idiopathic gonadotropin-dependent precocious puberty in girls with and without electroencephalographic abnormalities.

CONTEXT: gamma-Aminobutyric acid (GABA) is a dominant inhibitory neurotransmitter involved in the modulation of brain electric activity and puberty onset in primates. GABA inhibitory effects on GnRH neurons are mainly mediated by GABA-A receptor alpha1-subunit. OBJECTIVE: The objective of this study was to investigate functional mutations or polymorphisms of the GABA-A receptor alpha1-subunit gene (GABRA1) in girls with idiopathic gonadotropin-dependent precocious puberty (GDPP) with and without electroencephalographic (EEG) abnormalities. DESIGN: The entire coding region of GABRA1 was sequenced in all patients. Two known GABRA1 polymorphisms were investigated by GeneScan software analysis or enzymatic restriction. Seventy-three normal women were used as controls for genetic study. EEG tracings were recorded in 23 girls with GDPP and 17 girls with adequate pubertal development. SETTING: The study was performed at a university hospital. PATIENTS: Thirty-one girls from 28 unrelated families with idiopathic GDPP were studied. RESULTS: Automatic sequencing revealed no functional mutations in girls with GDPP. Seven different GABRA1 polymorphisms, including two exonic (156T>C and 1323G>A) and five intronic [IVS2-712(GT)n, IVS3+12A>T, IVS8+45T>G, IVS9+76A>G, and IVS10+15G>A], were found in GDPP girls and controls. Abnormal EEG tracings were found in 26% of 23 girls with GDPP, two of them with epilepsy. The genotype and allele frequencies of the GABRA1 polymorphisms were not statistically different between unrelated GDPP girls and controls or between GDPP girls with or without EEG abnormalities. CONCLUSIONS: GABRA1 functional mutations or polymorphisms are not associated with the intrinsic mechanism of GDPP in girls with and without EEG abnormalities.

Brainstem auditory evoked response in normal term neonates

Brainstem auditory evoked response (BAER) is a reliable test for neonatal auditory and neurological dysfunction and it permits early diagnosis and rehabilitation. The purpose of this study is to demonstrate latencies of BAER in normal term neonates in order to obtain reference values in a university hospital. BAER was performed in the second day of life in 47 normal newborns (25 male, 22 female) which gestational ages were higher than 37 and lower than or equal to 40 weeks that did not present familial history of deafness. The exam was performed with 80 dBHL alternating polarity 10/sec clicks presented monaurally. Two thousand stimulus trials were averaged and duplicated for each ear. Mean wave latencies in msec was: I, 1.79 (SD 0.20); II, 2.88 (SD 0.28); III, 4.54 (SD 0.31); IV, 5.86 (SD 0.36); V, 6.75 (SD 0.38); inter-peak latencies (IPL) I-III, 2.75 (SD 0.36); IPL III-V, 2.22 (SD 0.22); and IPL I-V, 4.97 (SD 0.43)

Syndromic classification of patients with typical absence seizures.

The aim of this study is to compare ILAE classification (1989) and Panayiotopoulos' criteria (1997) for absence epilepsies. We studied 455 typical absences (ILAE, 1981) by video-EEG in 43 patients with normal neurological and neuroradiological examinations and interictal EEG with spike-wave complexes higher than 2.5Hz. Syndromic diagnosis was possible in 60.5% and 67.4% of the patients using ILAE classification and Panayiotopoulos' proposal, respectively. According to ILAE criteria 19 patients had childhood absence epilepsy (CAE), five juvenile absence epilepsy (JAE), one juvenile myoclonic epilepsy (JME) and one epilepsy with specific modes of seizure precipitation. According to Panayiotopoulos' proposal, 10 had CAE, 14 JAE, one JME, three myoclonic absence epilepsy and one eyelid myoclonia with absences. We conclude that Panayiotopoulos' criteria and ILAE classification for absence epilepsies, which did not allow for the classification of 32.6% and 39.5% of cases, respectively, were still insufficient to classify all patients under specific diagnosis.

Syndromic classification of patients with typical absence seizures

The aim of this study is to compare ILAE classification (1989) and Panayiotopoulos' criteria (1997) for absence epilepsies. We studied 455 typical absences (ILAE, 1981) by video-EEG in 43 patients with normal neurological and neuroradiological examinations and interictal EEG with spike-wave complexes higher than 2.5Hz. Syndromic diagnosis was possible in 60.5 percent and 67.4 percent of the patients using ILAE classification and Panayiotopoulos' proposal, respectively. According to ILAE criteria 19 patients had childhood absence epilepsy (CAE), five juvenile absence epilepsy (JAE), one juvenile myoclonic epilepsy (JME) and one epilepsy with specific modes of seizure precipitation. According to Panayiotopoulos' proposal, 10 had CAE, 14 JAE, one JME, three myoclonic absence epilepsy and one eyelid myoclonia with absences. We conclude that Panayiotopoulos' criteria and ILAE classification for absence epilepsies, which did not allow for the classification of 32.6 percent and 39.5 percent of cases, respectively, were still insufficient to classify all patients under specific diagnosis

Brainstem auditory evoked response in normal term neonates.

Brainstem auditory evoked response (BAER) is a reliable test for neonatal auditory and neurological dysfunction and it permits early diagnosis and rehabilitation. The purpose of this study is to demonstrate latencies of BAER in normal term neonates in order to obtain reference values in a university hospital. BAER was performed in the second day of life in 47 normal newborns (25 male, 22 female) which gestational ages were higher than 37 and lower than or equal to 40 weeks that did not present familial history of deafness. The exam was performed with 80 dBHL alternating polarity 10/sec clicks presented monaurally. Two thousand stimulus trials were averaged and duplicated for each ear. Mean wave latencies in msec was: I, 1.79 (SD 0.20); II, 2.88 (SD 0.28); III, 4.54 (SD 0.31); IV, 5.86 (SD 0.36); V, 6.75 (SD 0.38); inter-peak latencies (IPL) I-III, 2.75 (SD 0.36); IPL III-V, 2.22 (SD 0.22); and IPL I-V, 4.97 (SD 0.43).

Coréia de Sydenham: revisäo da literatura / Sydenham's Chorea: literature review

A coréia de Sydenham, descrita em 1685 por Thomas Sydenham, caracteriza-se pelo aparecimento de movimentos involuntários arrítmicos, hipotonia muscular e é, por vezes, acompanhada de distúrbios psicológicos. Já no século XIX a coréia de Sydenham foi associada a infecçäo estreptocócica prévia e é considerada atualmente uma das manifestaçöes maiores da febre reumática. Anticorpos antineuronais säo descritos em 46 por cento dos casos e especula-se que possam representar reaçäo cruzada às membranas do Streptococcus do grupo A. Episódios recorrentes säo observados em 20-30 por cento dos casos. Tratamento sintomático com neurolépticos ou ácido valpróico é recomendado em pacientes incapacitados